ATE100313T1 - Oral verabreichbare ibuprofen enthaltende mittel. - Google Patents

Oral verabreichbare ibuprofen enthaltende mittel.

Info

Publication number
ATE100313T1
ATE100313T1 AT90302750T AT90302750T ATE100313T1 AT E100313 T1 ATE100313 T1 AT E100313T1 AT 90302750 T AT90302750 T AT 90302750T AT 90302750 T AT90302750 T AT 90302750T AT E100313 T1 ATE100313 T1 AT E100313T1
Authority
AT
Austria
Prior art keywords
containing compositions
orally administrated
ibuprofen containing
ibuprofen
administrated
Prior art date
Application number
AT90302750T
Other languages
English (en)
Inventor
Solomon Motola
Annabelle Mogavero
Gary R Agisim
Pamela N Panopoulos
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of ATE100313T1 publication Critical patent/ATE100313T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT90302750T 1989-03-28 1990-03-15 Oral verabreichbare ibuprofen enthaltende mittel. ATE100313T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/329,624 US4975465A (en) 1989-03-28 1989-03-28 Orally administrable ibuprofen compositions

Publications (1)

Publication Number Publication Date
ATE100313T1 true ATE100313T1 (de) 1994-02-15

Family

ID=23286273

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90302750T ATE100313T1 (de) 1989-03-28 1990-03-15 Oral verabreichbare ibuprofen enthaltende mittel.

Country Status (15)

Country Link
US (1) US4975465A (de)
EP (1) EP0390369B1 (de)
JP (1) JP2847134B2 (de)
KR (1) KR0143899B1 (de)
AR (1) AR245366A1 (de)
AT (1) ATE100313T1 (de)
AU (1) AU629622B2 (de)
CA (1) CA1336819C (de)
DE (1) DE69006068T2 (de)
DK (1) DK0390369T3 (de)
ES (1) ES2048428T3 (de)
HK (1) HK68194A (de)
IE (1) IE64024B1 (de)
MX (1) MX173433B (de)
NZ (1) NZ233102A (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994041A (en) * 1985-04-06 1999-11-30 Eastman Kodak Company Process for buffering concentrated aqueous slurries
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
AU2584092A (en) * 1992-09-03 1994-03-29 Affinity Biotech, Inc. Taste-masking pharmaceutical compositions and methods for making the same
EP0620001A1 (de) * 1993-04-16 1994-10-19 McNEIL-PPC, INC. Wässrige pharmazeutische Suspension und Verfahren zu ihrer Herstellung
DE4327147C2 (de) * 1993-08-12 1996-12-19 Klinge Co Chem Pharm Fab Arzneimittelzusammensetzung, welche neben dem Wirkstoff ein Gemisch aus Gelatine unterschiedlicher Löslichkeit enthält
FR2713931B1 (fr) * 1993-12-20 1996-04-05 Laurence Paris Nouvelles compositions pharmaceutiques liquides à base d'ibuprofène et leur procédé de préparation.
US5609998A (en) * 1994-12-29 1997-03-11 Eastman Kodak Company Process for dispersing concentrated aqueous slurries
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
CN1220598A (zh) * 1996-05-02 1999-06-23 大正制药株式会社 水难溶性酸性药物的悬浮液
GB9625589D0 (en) 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
DE69918105T2 (de) 1998-04-29 2005-07-07 Sumitomo Pharmaceuticals Co., Ltd. Orale zubereitung enthaltend einen biguanid und eine organische säure
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
EP1411899B1 (de) * 2001-08-01 2009-03-11 Novartis AG Zusammensetzung zur maskierung des geschmacks
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
ES2197781B1 (es) * 2001-12-04 2005-02-16 Farmalider, S.A. Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
WO2003077842A2 (en) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
US7300670B2 (en) 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
CN101862292A (zh) * 2002-06-17 2010-10-20 塔罗制药美国公司 布洛芬混悬剂
KR100509432B1 (ko) * 2002-12-13 2005-08-22 주식회사 동구제약 Ｓ(+)-이부프로펜을 함유한 시럽제 조성물 및 그의 제조방법
FR2850275B1 (fr) 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
DK1589944T3 (da) * 2003-02-06 2012-03-19 Gebro Pharma Gmbh Farmaceutiske tilberedninger og fremgangsmåde til produktion heraf
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
WO2005037264A1 (ja) * 2003-10-17 2005-04-28 Medrx Co., Ltd. ビグアナイド系薬剤を含有するゼリー製剤
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
GB2407497A (en) * 2003-10-30 2005-05-04 John Anthony Walters Method and formulation for the rapid and stable taste-masking of insoluble pharmaceutically active compounds using a surfactant and a hydrocolloid
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050266031A1 (en) * 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
DK2486942T3 (en) * 2004-11-24 2019-01-28 Meda Pharmaceuticals Inc COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
WO2008064192A2 (en) 2006-11-21 2008-05-29 Mcneil-Ppc, Inc. Modified release analgesic suspensions
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
US8362083B2 (en) * 2008-01-15 2013-01-29 C.B. Fleet Company Inc. Taste-masked docusate compositions
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
CA3023121A1 (en) * 2011-04-11 2012-10-18 Vitux Group As Oral pharmaceutical dispersion compositions
WO2013142482A1 (en) 2012-03-20 2013-09-26 Particle Dynamics International, Llc Gelling agent-based dosage form
MA58173B1 (fr) * 2019-12-23 2024-03-29 Nutra Essential Otc S L Composition liquide comprenant de l'ibuprofène et de la phényléphrine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145440A (en) * 1977-08-18 1979-03-20 The Upjohn Company Liquid suspension of an aluminum salt of ibuprofen
US4361580A (en) * 1980-06-20 1982-11-30 The Upjohn Manufacturing Company Aluminum ibuprofen pharmaceutical suspensions
US4631580A (en) * 1984-11-09 1986-12-23 John Taube Video-stereoscopic-image-producing system
GB8609566D0 (en) * 1986-04-18 1986-05-21 Boots Co Plc Analgesic method
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions

Also Published As

Publication number Publication date
US4975465A (en) 1990-12-04
AU629622B2 (en) 1992-10-08
IE64024B1 (en) 1995-06-28
AR245366A1 (es) 1994-01-31
JPH02286615A (ja) 1990-11-26
DE69006068T2 (de) 1994-05-11
HK68194A (en) 1994-07-22
ES2048428T3 (es) 1994-03-16
AU5226990A (en) 1990-10-04
DK0390369T3 (da) 1994-04-11
DE69006068D1 (de) 1994-03-03
EP0390369A3 (de) 1991-05-15
KR0143899B1 (ko) 1998-07-15
KR900013952A (ko) 1990-10-22
EP0390369A2 (de) 1990-10-03
EP0390369B1 (de) 1994-01-19
JP2847134B2 (ja) 1999-01-13
NZ233102A (en) 1991-08-27
IE901119L (en) 1990-09-28
MX20055A (es) 1993-10-01
CA1336819C (en) 1995-08-29
MX173433B (es) 1994-03-03

Similar Documents

Publication Publication Date Title
DE69006068D1 (de) Oral verabreichbare Ibuprofen enthaltende Mittel.
FI862479L (fi) Oral farmaceutisk komposition.
DE68909974D1 (de) Orales Präparat gegen Zahnstein.
FI922364L (fi) Farmaceutiska kompositioner.
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
FI922325L (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
DE68901492D1 (de) Orale zusammensetzungen.
FI870511A0 (fi) Orala kompositioner.
NO870961D0 (no) Fast tannsten-motvirkende munnpleiemiddel.
IT8920486A0 (it) Composizioni farmaceutiche.
DE68901390D1 (de) Orale zusammensetzung gegen zahnstein.
DE68902629D1 (de) Orale zusammensetzung.
FI903759A0 (fi) Farmaceutisk komposition innehaollande n-acetylcystein foer oral administrering.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI872733L (fi) Farmaceutiska kompositioner.
FI893643L (fi) Farmaceutiska kompositioner.
FI872554A7 (fi) Suukoostumuksia.
DE3673761D1 (de) Feste orale antikariogenische zusammensetzung.
NO871226D0 (no) Munnpleiemiddel som virker mot plaque.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
FI893740L (fi) Orala aemneskompositioner.
DE3852599D1 (de) Orale Zusammensetzungen.
FI872313A7 (fi) Farmaseuttisia ainekoostumuksia.
FI910088L (fi) Oral farmaceutisk komposition.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time